Wave Life Sciences, Inc. (WVE) earnings
WVE earnings moved a median of +2.49% by the close. Quarterly and annual WVE reports and results, each read against the price at its own news timestamp. Back to the WVE overview →
33 measured WVE earnings events.
Where these WVE earnings landedvs 33 measured WVE earnings reactions
| Middle 50% of WVE earnings reactions | -3.01% to +5.48% |
|---|---|
| Median reaction (to close) | +2.49% |
| Measured reactions | 33 |
Point-in-time · zero look-ahead
Half of the 33 WVE earnings events with a measured close landed between -3.01% and +5.48%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Wave Life Sciences Ltd. For: Jun 30 | SEC filing · Form 10-Q | +1.07% | +2.49% | |
| Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | +1.07% | +2.49% | |
| Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026 | Press release | +1.69% | +2.66% | |
| Form 10-K/A Wave Life Sciences Ltd. For: Dec 31 | SEC filing · Form 10-K | -0.99% | +3.39% | |
| Form 10-Q Wave Life Sciences Ltd. For: Mar 31 | SEC filing · Form 10-Q | -1.25% | +4.16% | |
| Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | -1.25% | +4.16% | |
| Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026 | Press release | -0.40% | -0.94% | |
| Form 10-K Wave Life Sciences Ltd. For: Dec 31 | SEC filing · Form 10-K | -0.28% | +5.71% | |
| Form 10-Q Wave Life Sciences Ltd. For: Sep 30 | SEC filing · Form 10-Q | +1.41% | -9.62% | |
| Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | +1.41% | -9.62% | |
| Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025 | Press release | +1.06% | -0.13% | |
| Form 10-Q Wave Life Sciences Ltd. For: Jun 30 | SEC filing · Form 10-Q | -0.49% | -0.73% | |
| Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | -0.49% | -0.73% | |
| Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025 | Press release | -0.31% | +7.00% | |
| Form 10-Q Wave Life Sciences Ltd. For: Mar 31 | SEC filing · Form 10-Q | -1.94% | +5.48% | |
| Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | -1.94% | +5.48% | |
| Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025 | Press release | -2.28% | +3.38% | |
| Form 10-K/A Wave Life Sciences Ltd. For: Dec 31 | SEC filing · Form 10-K | -0.42% | +7.22% | |
| Form 10-K Wave Life Sciences Ltd. For: Dec 31 | SEC filing · Form 10-K | +2.68% | +9.56% | |
| Form 10-Q Wave Life Sciences Ltd. For: Sep 30 | SEC filing · Form 10-Q | -1.01% | -0.03% | |
| Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | +5.11% | +6.15% | |
| Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024 | Press release | -0.94% | +0.36% | |
| Form 10-Q Wave Life Sciences Ltd. For: Jun 30 | SEC filing · Form 10-Q | -1.33% | -4.81% | |
| Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | -1.33% | -4.81% | |
| Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024 | Press release | -0.23% | -5.52% | |
| Form 10-Q Wave Life Sciences Ltd. For: Mar 31 | SEC filing · Form 10-Q | +0.17% | -4.75% | |
| Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | +2.41% | +6.87% | |
| Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024 | Press release | +0.87% | +2.80% | |
| Form 10-K/A Wave Life Sciences Ltd. For: Dec 31 | SEC filing · Form 10-K | +2.09% | +2.92% | |
| Form 10-K Wave Life Sciences Ltd. For: Dec 31 | SEC filing · Form 10-K | +16.73% | +22.37% | |
| Form 10-Q Wave Life Sciences Ltd. For: Sep 30 | SEC filing · Form 10-Q | -5.81% | -10.94% | |
| Wave Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | -5.81% | -10.94% | |
| Wave Life Sciences Third Quarter 2023 Financial Results Scheduled for November 9, 2023 | Press release | +0.89% | -3.01% |
Keep exploring
More WVE: analyst actions → · SEC filings → · WVE overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Verona Pharma plc - American Depositary Shares (VRNA) | 325 | -0.03% | 39% |
| Bionano Genomics, Inc. (BNGO) | 321 | -0.94% | 31% |
| Pulse Biosciences, Inc (PLSE) | 320 | +0.18% | 55% |
| Voyager Therapeutics, Inc. (VYGR) | 320 | -0.12% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.